Stocks and Investing Stocks and Investing
Thu, October 3, 2024
Wed, October 2, 2024
Tue, October 1, 2024

David Nierengarten Initiated (catx) at Buy and Held Target at $25 on, Oct 1st, 2024


Published on 2024-10-28 14:33:12 - WOPRAI
  Print publication without navigation


David Nierengarten of Wedbush, Initiated "Perspective Therapeutics, Inc." (CATX) at Buy and Held Target at $25 on, Oct 1st, 2024.

David has made no other calls on CATX in the last 4 months.



There are 5 other peers that have a rating on CATX. Out of the 5 peers that are also analyzing CATX, 0 agree with David's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with David


  • Nicole Germino of "Truist Securities" Initiated at Strong Buy and Held Target at $21 on, Wednesday, September 25th, 2024
  • Louis Chen of "Cantor Fitzgerald" Reiterated at Buy on, Tuesday, September 10th, 2024
  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $27 on, Friday, August 16th, 2024
  • Jeff Jones of "Oppenheimer" Maintained at Buy with Decreased Target to $17 on, Tuesday, August 13th, 2024
  • Alec Stranahan of "B of A Securities" Initiated at Strong Buy and Held Target at $24 on, Thursday, July 25th, 2024